Compare Virgin Galactic Holdings, Inc. (SPCE) vs 10X Genomics Inc (TXG) Price & Performance

Virgin Galactic Holdings, Inc.Trade

10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

Virgin Galactic Holdings, Inc. vs 10X Genomics Inc — how do they compare? Virgin Galactic Holdings, Inc. trades at $2.78 (market cap $329.06M), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: 10X Genomics Inc is far larger — about 16.7× Virgin Galactic Holdings, Inc.'s market cap, and 10X Genomics Inc is trading nearer its 52-week high, Virgin Galactic Holdings, Inc. nearer its low. Which is the better fit depends on your goals.

	SPCE	TXG
Market Cap	$329.06M	$5.48B
Sector	Industrials	Health
52-Week High	$7.52	$45.80
52-Week Low	$2.17	$11.34
Enterprise Value	$428.90M	$5.02B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

SPCE

Anthropic in talks to lease $10B computing power from Meta, following SpaceX deal.CNBC · 4 days agoBullish View details →

TXG

New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

About Virgin Galactic Holdings, Inc.

Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.